<i>MGMT</i> Promoter Methylation and Chemotherapy Outcomes in Low-Grade and Anaplastic Gliomas

MGMT Promoter Methylation and Chemotherapy Outcomes in Low-Grade and Anaplastic Gliomas—Reply

Published:2023-12-01 Issue:12 Volume:9 Page:1735
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Kinslow Connor J.¹²,Cheng Simon K.¹²,Wang Tony J. C.¹²

Affiliation:

1. Department of Radiation Oncology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York

2. Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2810746/jamaoncology_kinslow_2023_lr_230026_1702491836.88915.pdf

Reference6 articles.

1. Association of MGMT promoter methylation with survival in low-grade and anaplastic gliomas after alkylating chemotherapy.;Kinslow;JAMA Oncol,2023

2. Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.;Garton;J Neurosurg,2020

3. International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors.;Lassman;Neuro Oncol,2011

4. MGMT promoter methylation predicts overall survival after chemotherapy for 1p/19q-codeleted gliomas.;Kinslow;Clin Cancer Res

5. What is a glioblastoma?;Lassman;Neuro Oncol,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas;Neuro-Oncology;2024-06-29

2. MGMT promoter methylation in 1p19q-intact gliomas;Journal of Neuro-Oncology;2023-12-20